Bemis Company, Inc. has announced that Adele M. Gulfo was elected to the Board of Directors. The appointment became effective June 23, 2015.
Gulfo has served as chief strategy officer of Mylan N.V., a leading global pharmaceutical company, since 2014. Prior to joining Mylan, she spent four years at Pfizer, Inc., most recently as president, Latin America, and before that as president and general manager, U.S. Primary Care. Previously, Gulfo held leadership positions at AstraZeneca Pharmaceuticals, Parke-Davis (Division of Warner-Lambert), SpectraTech Inc., and Fischer Scientific.
“We are pleased that Adele is joining our Board of Directors,” says William F. Austen, Bemis Company’s president and CEO. “She brings valuable pharmaceutical, marketing and strategic insight to our board. We look forward to her contributions and energy.”